Medigen Vaccine Biologics Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was TWD 212.16 million compared to TWD 140.37 million a year ago. Basic loss per share from continuing operations was TWD 0.65 compared to TWD 0.44 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.3 TWD | -1.35% | +5.77% | -26.82% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.82% | 517M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |
- Stock Market
- Equities
- 6547 Stock
- News Medigen Vaccine Biologics Corporation
- Medigen Vaccine Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023